Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome
Clinical Endocrinology Jan 19, 2019
Dokras A, et al. - Among 87 overweight/obese women with polycystic ovary syndrome (PCOS) at two academic centres, researchers analyzed the impacts of oral contraceptive pills (OCP), the first-line treatment for PCOS, on high-density lipoprotein cholesterol (HDL-C) function (reverse cholesterol efflux capacity) and lipoprotein particles measured using nuclear magnetic resonance spectroscopy. Findings suggested an association of oral contraceptive pills use with improved HDL-C function and a concomitant atherogenic low-density lipoprotein cholesterol (LDL-C) profile. They observed that combining a Lifestyle program with the use of OCP improved HDL-C function and reduced the adverse effects of OCP on lipoproteins. The investigation shows that OCP is used in overweight/obese women with PCOS in combination with changes in Lifestyle.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries